We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma.
- Authors
Martin, William G; Ristow, Kay M; Habermann, Thomas M; Colgan, Joseph P; Witzig, Thomas E; Ansell, Stephen M
- Abstract
Bleomycin pulmonary toxicity (BPT) has been well described in Hodgkin's lymphoma (HL) patients treated with bleomycin-containing chemotherapy regimens. The influence of this pulmonary complication, along with the omission of bleomycin from further chemotherapy, on overall survival (OS) and progression-free survival (PFS) in HL remains unclear. We reviewed our experience with BPT in HL to better delineate outcome and appropriate treatment in these patients.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 30, p7614
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.02.7243